Use of D-MeAla3-EtVal4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said D-MeAla3-EtVal4-cyclosporin

摘要

Disclosed is the use of [D-MeAla]3-[EtVal]4-CsA (cyclosporin) for the manufacture of a medicinal product intended for the treatment of hepatitis C (HCV) infection or the prevention of HCV recurrence, wherein EtVal is N-ethyl-L-valine.